Cohort A: Vilobelimab, Cohort B: Paridiprubart, Cohort C: Bevacizumab
Ards, Acute Respiratory Distress Syndrome (Ards), Acute Respiratory Distress Syndrome, Ards (Acute Respiratory Distress Syndrome)
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
―